Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2019 | 12-2018 | 06-2018 | 12-2017 | 09-2017 | |
| Sales | 7,727,001 | 4,444,678 | 4,138,473 | 0 | 0 |
| Cost of Goods | 2,735,387 | 1,232,775 | 1,109,428 | 0 | 0 |
| Gross Profit | 4,991,614 | 3,211,903 | 3,029,045 | 0 | 0 |
| Operating Expenses | 4,902,221 | 2,211,748 | 2,119,869 | 0 | 0 |
| Operating Income | 89,781 | 1,000,930 | 909,604 | 0 | 0 |
| Interest Expense | 419,182 | 198,248 | 136,105 | 0 | 0 |
| Other Income | 100,209 | -379,051 | 90,040 | 0 | 0 |
| Pre-tax Income | -229,193 | 423,631 | 863,540 | 0 | 0 |
| Income Tax | -41,405 | 86,642 | 145,204 | 0 | 0 |
| Net Income Continuous | -187,788 | 336,990 | 718,336 | 0 | 0 |
| Minority Interests | 218 | 872 | -1,490 | 0 | 0 |
| Net Income | $-188,006 | $336,117 | $719,826 | $0 | $0 |
| EPS Basic Total Ops | -0.06 | 0.21 | 0.46 | N/A | N/A |
| EPS Basic Continuous Ops | -0.06 | 0.22 | 0.46 | N/A | N/A |
| EPS Diluted Total Ops | -0.06 | 0.21 | 0.46 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.06 | 0.21 | 0.46 | N/A | N/A |
| EBITDA(a) | $1,694,401 | $1,000,929 | $909,604 | $0 | $0 |